Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Active Not Recruiting2
Withdrawn1

Clinical Trials (3)

Showing 3 of 3 trials
NCT04580771Phase 2Active Not Recruiting

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

NCT04574635Active Not Recruiting

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

NCT05093712Withdrawn

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Showing all 3 trials

Research Network

Activity Timeline